CELERITAS BIOSCIENCE
Home About Us Approach Pipeline Investors Contact
Investor Inquiries

Important Legal Notice.

Last updated: May 2026

These disclosures govern celeritasbio.com (the “Site”) and the development activities of Celeritas Bioscience Inc. (“Celeritas”).

Informational purpose

The Site is provided for informational purposes only. Nothing on the Site constitutes medical advice, a prospectus, an offering memorandum, or a solicitation to invest. Site content should not be relied upon as a basis for medical, financial, or investment decisions.

Development-stage company

Celeritas is a development-stage company. No Celeritas product candidate has been approved by the U.S. Food and Drug Administration, Health Canada, or any other regulatory authority. No investigational application has been filed; no clinical trial has been initiated or completed.

Observational data

Observational data referenced on the Site or in supporting materials is anecdotal and patient-reported. No controlled clinical study has been conducted. Past observations are not predictive of future clinical outcomes and do not establish safety or efficacy for any Celeritas product candidate.

No therapeutic claims

Nothing on the Site constitutes a claim of safety, efficacy, diagnosis, treatment, cure, or prevention of any disease or medical condition. Category-level statements regarding phytopharmaceutical and botanical drug attributes describe approved products in the regulated category generally; they are not claims about any specific Celeritas product candidate.

Forward-looking statements

The Site contains forward-looking statements regarding Celeritas’s product candidates, development plans, and corporate strategy. These statements involve substantial risks and uncertainties and are not guarantees of future performance. Future development activities are contingent upon financing, regulatory authorization, and successful clinical investigation. Actual results may differ materially from those projected.

Privacy Policy.

Last updated: May 2026

Celeritas Bioscience Inc. (“Celeritas”) respects your privacy. This Privacy Policy explains how Celeritas collects, uses, and safeguards information when you visit celeritasbio.com (the “Site”).

Information collected

Celeritas collects two categories of information. First, information you voluntarily provide — name, email address, organization, and message content — through contact, media, or investor inquiry channels. Second, anonymized technical data automatically recorded by the Site, including pages visited, referring URL, browser type, device type, and IP-derived region.

Use of information

Celeritas uses information to respond to inquiries, fulfill requests, maintain Site security, and analyze aggregated usage patterns to improve the Site experience. Submitted information is not used for marketing purposes without your consent.

Sharing and third parties

Celeritas does not sell, rent, or trade personal information with third parties for marketing purposes. Limited third-party services support Site operations, including Google Fonts (typography delivery) and standard server access logging for diagnostics and security. These services may process technical data consistent with their own published privacy practices.

Cookies and tracking

The Site does not deploy advertising cookies. Anonymous analytics cookies may be used to measure aggregate usage. Most browsers allow you to disable cookies through their settings; some Site functionality may be affected as a result.

Data retention

Voluntary submissions are retained only as long as necessary to respond to your inquiry or to comply with applicable legal obligations. Anonymized technical data may be retained in aggregated form for analytical purposes.

Your rights

Subject to applicable law, you may request access to, correction of, or deletion of personal information you have provided. Requests should be sent to contact@celeritasbio.com. Celeritas will respond within a reasonable timeframe.

International users

Celeritas is based in North America. By using the Site or submitting information, users located outside this region consent to the transfer and processing of their information consistent with this Policy.

Children’s privacy

The Site is not directed at children under 13, and Celeritas does not knowingly collect personal information from children.

Changes to this policy

Celeritas may update this Privacy Policy periodically. Material changes will be reflected by a revised “Last updated” date at the top of this section. Continued use of the Site after revisions constitutes acceptance of the updated Policy.

Contact

Questions or requests relating to this Privacy Policy should be directed to contact@celeritasbio.com.

Terms of Use.

Last updated: May 2026

These Terms of Use (the “Terms”) govern your access to and use of celeritasbio.com (the “Site”), operated by Celeritas Bioscience Inc. (“Celeritas”). By accessing or using the Site, you agree to these Terms. If you do not agree, do not use the Site.

No medical advice

The Site is for informational purposes only. Nothing on the Site constitutes medical advice, diagnosis, treatment, cure, or prevention of any disease or medical condition. Consult a qualified healthcare professional before making decisions about your health.

No offer of securities

Nothing on the Site constitutes an offer to sell, or a solicitation of an offer to buy, any securities. The Site is not a prospectus or offering memorandum. Any future offer of securities, if and when made, will be conducted only through formal offering documents and appropriate regulatory channels.

Forward-looking statements

The Site contains forward-looking statements regarding Celeritas’s development plans, programs, and strategy. These statements are subject to substantial risks and uncertainties and are not guarantees of future performance.

Intellectual property

All Site content — including text, graphics, logos, images, and software — is the property of Celeritas or its licensors and is protected by copyright, trademark, and other intellectual property laws. No content may be reproduced, distributed, modified, or commercially exploited without prior written consent from Celeritas, except for personal, non-commercial reference.

Permitted use

You may use the Site only for lawful purposes. You agree not to attempt to gain unauthorized access to any portion of the Site, interfere with its operation, or use automated means to scrape, harvest, or collect data.

Third-party links

The Site may contain links to third-party websites or services. Celeritas does not control, endorse, or assume responsibility for the content, policies, or practices of any third party.

Disclaimer of warranties

The Site is provided on an “as is” and “as available” basis, without warranties of any kind, whether express or implied, including warranties of merchantability, fitness for a particular purpose, non-infringement, or uninterrupted operation.

Limitation of liability

To the maximum extent permitted by law, Celeritas and its affiliates, officers, directors, employees, and agents shall not be liable for any direct, indirect, incidental, consequential, special, or punitive damages arising from or related to your access to, use of, or inability to access or use, the Site.

Modifications

Celeritas may modify these Terms at any time. Material changes will be reflected by a revised “Last updated” date at the top of this section. Continued use of the Site following any modification constitutes acceptance of the revised Terms.

Governing law

These Terms are governed by the laws applicable in the jurisdiction in which Celeritas is organized, without regard to conflict-of-laws principles.

Contact

Questions about these Terms should be directed to contact@celeritasbio.com.

CELERITAS BIOSCIENCE

Botanically derived.
Empirically observed.
Clinically pursued.

Company

Approach Pipeline Investors

Connect

contact@celeritasbio.com investors@celeritasbio.com Press

Legal

Disclosures Privacy Terms

Important Legal Notice

Informational purposes only — not medical advice, a prospectus, or a solicitation to invest. Contains forward-looking statements subject to substantial risk and uncertainty. Celeritas Bioscience Inc. is a development-stage company; no product candidate has been approved by the FDA, Health Canada, or any regulatory authority. No investigational application has been filed and no clinical trial has been initiated or completed. Observational data referenced is anecdotal and patient-reported. Nothing herein constitutes a claim of safety, efficacy, diagnosis, treatment, cure, or prevention. Past observations are not predictive of future outcomes. Future development is contingent upon financing, regulatory authorization, and successful clinical investigation. See full disclosures →

© 2026 Celeritas Bioscience Inc.